for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Pfizer-BioNTech have yet to decide whether COVAX to handle vaccine pledge to poorer nations

BRUSSELS, May 21 (Reuters) - Pfizer and BionTech have yet to decide whether their new commitment, announced by Pfizer on Friday, to supply 2 billion COVID-19 vaccine doses to low- and middle-income countries will be handled by the international vaccine-sharing facility COVAX.

“We are currently still evaluating this,” said a BioNTech spokeswoman.

A Pfizer spokesman said he could not yet provide that information. (Reporting by Ludwig Burger, editing by Thomas Escritt)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up